Switch theme
Sign up to access all valuation multiples
SKAN Group AG is a global market and technological company for isolators, cleanroom devices, and decontamination processes for the aseptic production of biopharmaceutical substances. Its core competency is the design and development of process isolators for the aseptic filling of biopharmaceutical products. The company offer its customers process support, services, and consumables. Its products include biological indicators, isolators, Laboratory/cleanroom equipment, laminar flow, safety workbench, and transfer system. The Firm has three operating segment Equipment & solutions, Services & Consumables, and Other. The company generates the majority of its revenue from the Equipment & solutions segment. Geographically the company derives revenue from Asia, Europe, Americas, and Other regions.
1968
1.5K+
LTM Revenue $429M
LTM EBITDA $67.9M
$1.5B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
SKAN Group has a last 12-month revenue of $429M and a last 12-month EBITDA of $67.9M.
In the most recent fiscal year, SKAN Group achieved revenue of $409M and an EBITDA of $67.5M.
SKAN Group expects next 12-month revenue of XXX and NTM EBITDA of XXX
See SKAN Group valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $362M | $409M | XXX | XXX | XXX |
| Gross Profit | $227M | $272M | XXX | XXX | XXX |
| Gross Margin | 63% | 67% | XXX | XXX | XXX |
| EBITDA | $51.5M | $67.5M | XXX | XXX | XXX |
| EBITDA Margin | 14% | 17% | XXX | XXX | XXX |
| Net Profit | $21.5M | $29.8M | XXX | XXX | XXX |
| Net Margin | 6% | 7% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, SKAN Group's stock price is CHF 63 (or $71).
SKAN Group has current market cap of CHF 1.4B (or $1.6B), and EV of CHF 1.4B (or $1.5B).
See SKAN Group trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.5B | $1.6B | XXX | XXX | XXX | XXX | $2.03 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, SKAN Group has market cap of $1.6B and EV of $1.5B.
SKAN Group's trades at 3.6x LTM EV/Revenue multiple, and 22.6x LTM EBITDA.
Analysts estimate SKAN Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for SKAN Group and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $1.5B | XXX | XXX | XXX |
| EV/Revenue | 3.7x | XXX | XXX | XXX |
| EV/EBITDA | 22.7x | XXX | XXX | XXX |
| P/E | 36.2x | XXX | XXX | XXX |
| P/E/Growth | 2.0x | XXX | XXX | XXX |
| EV/FCF | -191.0x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpSKAN Group's NTM/LTM revenue growth is 18%
SKAN Group's revenue per employee for the last fiscal year averaged $0.3M, while opex per employee averaged $0.2M for the same period.
Over next 12 months, SKAN Group's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate SKAN Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for SKAN Group and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 13% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 17% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 31% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 34% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.3M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.2M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 1% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 4% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 61% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
SKAN Group acquired XXX companies to date.
Last acquisition by SKAN Group was XXXXXXXX, XXXXX XXXXX XXXXXX . SKAN Group acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was SKAN Group founded? | SKAN Group was founded in 1968. |
| Where is SKAN Group headquartered? | SKAN Group is headquartered in Switzerland. |
| How many employees does SKAN Group have? | As of today, SKAN Group has 1.5K+ employees. |
| Who is the CEO of SKAN Group? | SKAN Group's CEO is Mr. Thomas Huber. |
| Is SKAN Group publicy listed? | Yes, SKAN Group is a public company listed on SWX. |
| What is the stock symbol of SKAN Group? | SKAN Group trades under SKAN ticker. |
| When did SKAN Group go public? | SKAN Group went public in 2021. |
| Who are competitors of SKAN Group? | Similar companies to SKAN Group include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of SKAN Group? | SKAN Group's current market cap is $1.6B |
| What is the current revenue of SKAN Group? | SKAN Group's last 12-month revenue is $429M. |
| What is the current EBITDA of SKAN Group? | SKAN Group's last 12-month EBITDA is $67.9M. |
| What is the current EV/Revenue multiple of SKAN Group? | Current revenue multiple of SKAN Group is 3.6x. |
| What is the current EV/EBITDA multiple of SKAN Group? | Current EBITDA multiple of SKAN Group is 22.6x. |
| What is the current revenue growth of SKAN Group? | SKAN Group revenue growth between 2023 and 2024 was 13%. |
| Is SKAN Group profitable? | Yes, SKAN Group is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
